OCI NV (OCI.AS) Stock Fundamental Analysis
AMS:OCI - Euronext Amsterdam - NL0010558797 - Common Stock - Currency: EUR
We assign a fundamental rating of 2 out of 10 to OCI. OCI was compared to 61 industry peers in the Chemicals industry. OCI may be in some trouble as it scores bad on both profitability and health. OCI is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
OCI had negative earnings in the past year.
In the past year OCI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: OCI reported negative net income in multiple years.
OCI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -5.28%, OCI is not doing good in the industry: 65.57% of the companies in the same industry are doing better.
OCI has a Return On Equity of -51.53%. This is in the lower half of the industry: OCI underperforms 78.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROIC | N/A |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
In the last couple of years the Profit Margin of OCI has grown nicely.
Looking at the Gross Margin, with a value of 2.23%, OCI is doing worse than 81.97% of the companies in the same industry.
In the last couple of years the Gross Margin of OCI has declined.
OCI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
2. Health
2.1 Basic Checks
OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
OCI has about the same amout of shares outstanding than it did 1 year ago.
OCI has more shares outstanding than it did 5 years ago.
OCI has a better debt/assets ratio than last year.
2.2 Solvency
OCI has an Altman-Z score of 0.20. This is a bad value and indicates that OCI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of OCI (0.20) is worse than 80.33% of its industry peers.
The Debt to FCF ratio of OCI is 44.52, which is on the high side as it means it would take OCI, 44.52 years of fcf income to pay off all of its debts.
OCI has a worse Debt to FCF ratio (44.52) than 60.66% of its industry peers.
OCI has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.03, OCI is doing worse than 85.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Altman-Z | 0.2 |
ROIC/WACCN/A
WACC6.15%
2.3 Liquidity
OCI has a Current Ratio of 1.39. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
OCI's Current ratio of 1.39 is on the low side compared to the rest of the industry. OCI is outperformed by 63.93% of its industry peers.
OCI has a Quick Ratio of 1.37. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
OCI has a better Quick ratio (1.37) than 67.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
The earnings per share for OCI have decreased strongly by -123.19% in the last year.
OCI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 105.88% yearly.
The Revenue for OCI has decreased by -58.51% in the past year. This is quite bad
The Revenue for OCI have been decreasing by -20.30% on average. This is quite bad
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
3.2 Future
The Earnings Per Share is expected to grow by 71.49% on average over the next years. This is a very strong growth
Based on estimates for the next years, OCI will show a decrease in Revenue. The Revenue will decrease by -1.74% on average per year.
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue Next Year-14.75%
Revenue Next 2Y-5.25%
Revenue Next 3Y-21.85%
Revenue Next 5Y-1.74%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
OCI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 18.92, OCI is valued on the expensive side.
OCI's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.74, OCI is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 18.92 |
4.2 Price Multiples
The rest of the industry has a similar Price/Free Cash Flow ratio as OCI.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.91 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OCI's earnings are expected to grow with 133.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y251.29%
EPS Next 3Y133.31%
5. Dividend
5.1 Amount
OCI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:OCI (5/6/2025, 11:26:34 AM)
7.4
-0.06 (-0.8%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners32.2%
Inst Owner ChangeN/A
Ins Owners8.71%
Ins Owner ChangeN/A
Market Cap1.56B
Analysts80
Price Target14.02 (89.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend13.44
Dividend Growth(5Y)N/A
DP-36.26%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)486.8%
Min EPS beat(2)232.01%
Max EPS beat(2)741.58%
EPS beat(4)2
Avg EPS beat(4)85.49%
Min EPS beat(4)-492.57%
Max EPS beat(4)741.58%
EPS beat(8)3
Avg EPS beat(8)31.49%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)37.56%
Min Revenue beat(2)20.15%
Max Revenue beat(2)54.98%
Revenue beat(4)2
Avg Revenue beat(4)8.41%
Min Revenue beat(4)-23.05%
Max Revenue beat(4)54.98%
Revenue beat(8)5
Avg Revenue beat(8)21.58%
Revenue beat(12)9
Avg Revenue beat(12)32.19%
Revenue beat(16)12
Avg Revenue beat(16)36.43%
PT rev (1m)-14.05%
PT rev (3m)-12.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)151.4%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-11.11%
Revenue NY rev (3m)-11.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 18.92 | ||
| P/S | 0.39 | ||
| P/FCF | 32.91 | ||
| P/OCF | 3.21 | ||
| P/B | 1.93 | ||
| P/tB | 2.04 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.42
EYN/A
EPS(NY)0.39
Fwd EY5.29%
FCF(TTM)0.22
FCFY3.04%
OCF(TTM)2.31
OCFY31.17%
SpS18.99
BVpS3.84
TBVpS3.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.28% | ||
| ROE | -51.53% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 2.23% | ||
| FCFM | 1.18% |
ROA(3y)41.1%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score3
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | 44.53 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | -4159.17% | ||
| Cap/Sales | 10.96% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.39 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 0.2 |
F-Score3
WACC6.15%
ROIC/WACCN/A
Cap/Depr(3y)137.7%
Cap/Depr(5y)97.09%
Cap/Sales(3y)24.99%
Cap/Sales(5y)17.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-123.19%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%164.52%
EPS Next Y770.92%
EPS Next 2Y251.29%
EPS Next 3Y133.31%
EPS Next 5Y71.49%
Revenue 1Y (TTM)-58.51%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-11.72%
Revenue Next Year-14.75%
Revenue Next 2Y-5.25%
Revenue Next 3Y-21.85%
Revenue Next 5Y-1.74%
EBIT growth 1Y-118.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.92%
EBIT Next 3Y25.04%
EBIT Next 5Y23.97%
FCF growth 1Y-95.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.4%
OCF growth 3Y-68.9%
OCF growth 5Y-27.39%